| Endocrine disrupting chemicals and COVID-19 relationships: A computational systems biology approach Q Wu, X Coumoul, P Grandjean, R Barouki, K Audouze Environment International 157, 106232, 2021 | 50 | 2021 |
| A retrospective evaluation of allometry, population pharmacokinetics, and physiologically‐based pharmacokinetics for pediatric dosing using clearance as a surrogate Q Wu, SA Peters CPT: Pharmacometrics & Systems Pharmacology 8 (4), 220-229, 2019 | 32 | 2019 |
| Computational systems biology as an animal-free approach to characterize toxicological effects of persistent organic pollutants KA Qier Wu, Rayanne Achebouche ALTEX - Alternatives to animal experimentation 10 (161), 2020 | 16* | 2020 |
| Development of an adverse drug event network to predict drug toxicity Q Wu, O Taboureau, K Audouze Current Research in Toxicology 1, 48-55, 2020 | 12 | 2020 |
| Capturing a comprehensive picture of biological events from adverse outcome pathways in the drug exposome Q Wu, Y Bagdad, O Taboureau, K Audouze Frontiers in Public Health 9, 763962, 2021 | 3 | 2021 |
| Global network of adverse drug effects Q Wu, O Taboureau, K Audouze | | |
